Its products include DexCom G4 PLATINUM System, DexCom G5 Mobil, DexCom G6, and DexCom Share. Read More on DXCM: DexCom NewsMORE Related Stocks Indices Commodities ...
Oura and Dexcom are partnering on metabolic health — and they mean big business. Dexcom has invested $75 million into Oura to make the deal happen, valuing Oura at $5 billion. That works out to ...
Smart ring maker Oura announced on Tuesday that it has received a $75 million investment from glucose device maker Dexcom. The investment marks Oura’s Series D funding round and brings the ...
Smart ring company Oura announced it received $75 million in funding from glucose monitoring and diagnostics company Dexcom. The strategic investment brings Oura’s valuation to more than $5 ...
DexCom, Inc. (DXCM): Innovation and Growth Catalysts Amid Strong Long-Term Outlook for Diabetes Care
In this article, we are going to take a look at where DexCom, Inc. (NASDAQ:DXCM) stands against Well Fargo’s other growth stocks. With the interest rate cycle kicking off in the US, stocks that ...
Carillon Eagle Mid Cap Growth Fund highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that ...
Smart ring maker Oura Health Oy is getting a $75 million investment from medical device firm Dexcom Inc., setting the stage for the two companies to share data and cross-sell products. Dexcom is ...
Medical device company DexCom (NASDAQ: DXCM) specializes in the diabetes care space. DXCM and smart ring maker, OURA, join forces to help individuals make informed decisions regarding diet ...
In March, the FDA cleared Dexcom’s Stelo, making it the first glucose biosensor that doesn’t require a prescription. The small, wearable device, worn on the back of the upper arm, is designed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback